Sign In
Buy GTBP
$0.439
-0.0279 (-5.97%)
At Close: Jun 03, 2026
GT BioPharma's Next Generation Camelid TriKE® Nanobody Platform Highlighted at ESMO Congress 2021
07:00am, Monday, 20'th Sep 2021
BEVERLY HILLS, Calif., Sept. 20, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based o
OXIS International Inc. (GTBP) Moves to Buy: Rationale Behind the Upgrade
01:44pm, Thursday, 16'th Sep 2021
OXIS International Inc. (GTBP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BEVERLY HILLS, Calif., Sept. 15, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on
GT Biopharma Advances GTB-3650, a Second-Generation Tri-Specific Killer Engager -TriKE®, Into IND-Enabling Studies
07:00am, Monday, 13'th Sep 2021
BEVERLY HILLS, Calif., Sept. 13, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on
GT Biopharma to Present at Upcoming September Investor Conferences
12:28pm, Wednesday, 08'th Sep 2021
BEVERLY HILLS, Calif., Sept. 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's p
GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer
07:00am, Monday, 23'rd Aug 2021
BEVERLY HILLS, Calif., Aug. 23, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's p
GT Biopharma, Inc. (GTBP) CEO Tony Cataldo on Q2 2021 Results - Earnings Call Transcript
01:11pm, Friday, 13'th Aug 2021
GT Biopharma, Inc. (GTBP) CEO Tony Cataldo on Q2 2021 Results - Earnings Call Transcript
GT Biopharma Provides Second Quarter 2021 Business Update
07:30am, Friday, 13'th Aug 2021
BEVERLY HILLS, Calif., Aug. 13, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ther
Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win
01:02pm, Thursday, 12'th Aug 2021
Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.
Hot Biotech Stocks That Deserve Your Attention In August 2021
11:56am, Wednesday, 11'th Aug 2021
Is it time to add biotech stocks to your list this year? The post Hot Biotech Stocks That Deserve Your Attention In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
Are Penny Stocks Worth It? 5 That Deserve Your Attention Now
12:36pm, Thursday, 05'th Aug 2021
Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?
GTBP Stock Price Increases Over 6% Pre-Market: Why It Happened
08:19am, Tuesday, 03'rd Aug 2021
The stock price of GT Biopharma, Inc. (NASDAQ: GTBP) increased by over 6% pre-market. This is why it happened.
Former Biotech Penny Stocks Seeing Explosive Moves In 2021
10:53am, Monday, 02'nd Aug 2021
Are penny stocks worth it? Take a look at these 3 seeing explosive moves this year.
3 Biotech Penny Stocks To Watch On Robinhood IPO Day
01:11pm, Thursday, 29'th Jul 2021
These Former Penny Stocks Are Turning Heads Ahead Of Robinhood IPO The post 3 Biotech Penny Stocks To Watch On Robinhood IPO Day appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120%
11:51am, Friday, 23'rd Jul 2021
Former penny stocks biotech analysts are bullish on right now. The post 3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120% appeared first on Penny Stocks to Buy, Picks, News and In
